Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 |
filingDate |
2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_906dbbb1f7a47c478969fb95dadfc81c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2314e883a9c886f5b6466d12bcaea4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6ef6a4daf5f985c66ce1fbebe2d32a6 |
publicationDate |
2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014084378-A1 |
titleOfInvention |
Anticancer drug comprising cyclic rgd sequence-containing peptide |
abstract |
Provided is an anticancer drug which has advantages such as reduced gastrointestinal toxicity and less weight loss in patients. This anticancer drug comprises an anti-cancer active ingredient and a cyclic arginine-glycine-aspartic acid (RGD) sequence-containing peptide. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017002979-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7281140-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328116-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10946028-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021035972-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017110669-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022529413-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017537974-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017002979-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017110669-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2721725-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020213015-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014157584-A1 |
priorityDate |
2012-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |